Evaluating in Vivo Efficacy – Toxicity Profile of TEG001 in Humanized Mice Xenografts Against Primary Human AML Disease and Healthy Hematopoietic Cells

Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1186/s40425-019-0558-4

Related search